This course has expired. View available courses.
Neurology
The Role of Early DMTs and the Impact of COVID-19 on MS
Multiple Sclerosis (MS) is a chronic autoimmune disorder for which there is currently no cure. Management of MS during the COVID-19 pandemic created challenges for patients in the Kingdom and around the World. In this webinar, our panel of international experts will review the current COVID-19 protection and vaccine recommendations for patients with MS and NMOSD. Panelists will also discuss the updates on treatment management and new evidence with MS and NMOSD disease modifying therapies and how this will influence practice today and in the near future.
This activity is supported by an independent educational grant from Roche Products Saudi Arabia.
DURATION
1 hr
PROFESSION
Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2023-03-09
Multiple Sclerosis (MS) is a chronic autoimmune disorder for which there is currently no cure. Management of MS during the COVID-19 pandemic created challenges for patients in the Kingdom and around the World. In this webinar, our panel of international experts will review the current COVID-19 protection and vaccine recommendations for patients with MS and NMOSD. Panelists will also discuss the updates on treatment management and new evidence with MS and NMOSD disease modifying therapies and how this will influence practice today and in the near future.
This activity is supported by an independent educational grant from Roche Products Saudi Arabia.
Faculty
Mohammed Al Jumah, MBBS, MD, FRCPC
Yaser Al Malik, MD, FRCPC, ABPN, CSCN
Amani Alshehri, B Pharm, PharmD, BCPS, RPh, PGY2
Anthony Traboulsee, MD, FRCP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Develop treatment goals for patient with multiple sclerosis (MS)
- Discuss the considerations and benefits of early disease modifying treatment for patients with MS
- Review current recommendations for the management of Neuromyelitis optica spectrum disorders (NMOSD)
- Provide an overview of COVID-19 impact on the delivery of MS care
- Describe COVID-19 severity for patients with MS
- Review the current COVID-19 protection and vaccine recommendations for patients with MS